NFKBIA and colitis: In a study examining murine colitis-associated colon cancer, fluoxetine was found to inhibit NF-κB activation and decrease TNF-α-mediated IκB kinase (IKK) and IκBα phosphorylation; thus suppressing dextran sulfate sodium (DSS)-induced colitis and colitis-associated tumorigenesis [84].